Back to
VANGUARD GROUP INC
KLRS4 quarters
Position history for
VANGUARD GROUP INC's holdings in KALARIS THERAPEUTICS INC
As of its last 13F, for Q4 2025, Vanguard Group held 292,790 shares of KLRS (Kalaris Therapeutics), worth $2.5M. It increased the position by 89,739 shares (+44.2%) from Q3 2025. Vanguard Group held KLRS from Q1 2025 to Q4 2025, across 4 quarterly 13F filings.
Current Value
$2.5M
Current Shares
292,790
Total Value Change
+$1.5M
Total Shares Change
+177,704
Quarter-by-Quarter History
Other major holders of KLRS: RTW INVESTMENTS, LP, Alyeska Investment Group, L.P.